PMC:7461420 / 6067-6248 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T35","span":{"begin":60,"end":64},"obj":"Disease"},{"id":"T36","span":{"begin":72,"end":76},"obj":"Disease"}],"attributes":[{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ism. CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐converting enzyme 2 (ACE2); 14 , 15 , 16 MERS‐CoV uses dipeptidy"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T71","span":{"begin":24,"end":29},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"ism. CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐converting enzyme 2 (ACE2); 14 , 15 , 16 MERS‐CoV uses dipeptidy"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T24","span":{"begin":102,"end":113},"obj":"Chemical"}],"attributes":[{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"}],"text":"ism. CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐converting enzyme 2 (ACE2); 14 , 15 , 16 MERS‐CoV uses dipeptidy"}

{"project":"LitCovid-PubTator","denotations":[{"id":"231","span":{"begin":102,"end":133},"obj":"Gene"},{"id":"232","span":{"begin":135,"end":139},"obj":"Gene"},{"id":"236","span":{"begin":5,"end":9},"obj":"Species"},{"id":"237","span":{"begin":24,"end":29},"obj":"Species"},{"id":"238","span":{"begin":60,"end":68},"obj":"Species"},{"id":"239","span":{"begin":72,"end":82},"obj":"Species"},{"id":"240","span":{"begin":88,"end":97},"obj":"Species"},{"id":"241","span":{"begin":158,"end":166},"obj":"Species"}],"attributes":[{"id":"A231","pred":"tao:has_database_id","subj":"231","obj":"Gene:59272"},{"id":"A232","pred":"tao:has_database_id","subj":"232","obj":"Gene:59272"},{"id":"A236","pred":"tao:has_database_id","subj":"236","obj":"Tax:11118"},{"id":"A237","pred":"tao:has_database_id","subj":"237","obj":"Tax:9606"},{"id":"A238","pred":"tao:has_database_id","subj":"238","obj":"Tax:694009"},{"id":"A239","pred":"tao:has_database_id","subj":"239","obj":"Tax:2697049"},{"id":"A240","pred":"tao:has_database_id","subj":"240","obj":"Tax:277944"},{"id":"A241","pred":"tao:has_database_id","subj":"241","obj":"Tax:1335626"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ism. CoVs use different human receptors as points of entry: SARS‐CoV‐1, SARS‐CoV‐2, and HCoV‐NL63 use angiotensin‐converting enzyme 2 (ACE2); 14 , 15 , 16 MERS‐CoV uses dipeptidy"}